Severe winter asthma exacerbations can be prevented by omalizumab, but there is no carryover effect Peter D. Sly, MD, DSc, Julie Varghese, BHMS, PGDCTM, Farhana Noor, BSc (App Stats) MDS, Mimi L.K. Tang, MBBS, PhD, Ingrid Laing, PhD, Steve Oo, MBBS, Franciska Prastanti, MBBS, Peter N. LeSouef, MD, Patrick G. Holt, PhD, DSc Journal of Allergy and Clinical Immunology Volume 139, Issue 2, Pages 703-705.e4 (February 2017) DOI: 10.1016/j.jaci.2016.07.035 Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 1 Time to first severe exacerbation. The proportion of the active (n = 14) and placebo (n = 13) groups “surviving” without an acute severe exacerbation is shown at each visit. Journal of Allergy and Clinical Immunology 2017 139, 703-705.e4DOI: (10.1016/j.jaci.2016.07.035) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions